Petr Vladimirovich Kruglyakov
Chief Executive Officer at PHARMSYNTHEZ
Profile
Petr Vladimirovich Kruglyakov is currently the Director General at Pharmsynthez PJSC.
He previously worked as the Director-Research & Development at Artgen Biotech PJSC from 2010 to 2011 and as the Executive Director at SynBio LLC from 2013 to 2014.
Dr. Kruglyakov obtained his undergraduate degree from the State University of St. Petersburg.
Petr Vladimirovich Kruglyakov active positions
| Companies | Position | Start |
|---|---|---|
| PHARMSYNTHEZ | Chief Executive Officer | 01/01/2014 |
Former positions of Petr Vladimirovich Kruglyakov
| Companies | Position | End |
|---|---|---|
SynBio LLC
 SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Chief Executive Officer | 01/01/2013 |
| HUMAN STEM CELLS INSTITUTE | Chief Tech/Sci/R&D Officer | 01/01/2011 |
Training of Petr Vladimirovich Kruglyakov
| State University of St. Petersburg | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HUMAN STEM CELLS INSTITUTE | Health Services |
| PHARMSYNTHEZ | Health Technology |
| Private companies | 1 |
|---|---|
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
- Stock Market
- Insiders
- Petr Vladimirovich Kruglyakov
